Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA469540
Max Phase: Preclinical
Molecular Formula: C14H10ClF3N4O
Molecular Weight: 342.71
Molecule Type: Small molecule
Associated Items:
ID: ALA469540
Max Phase: Preclinical
Molecular Formula: C14H10ClF3N4O
Molecular Weight: 342.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: FC(F)(F)Oc1cccc(CNc2cc(Cl)nc3ccnn23)c1
Standard InChI: InChI=1S/C14H10ClF3N4O/c15-11-7-13(22-12(21-11)4-5-20-22)19-8-9-2-1-3-10(6-9)23-14(16,17)18/h1-7,19H,8H2
Standard InChI Key: RWTSXHLGBPUMJH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 342.71 | Molecular Weight (Monoisotopic): 342.0495 | AlogP: 3.89 | #Rotatable Bonds: 4 |
Polar Surface Area: 51.45 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.31 | CX LogP: 4.19 | CX LogD: 4.19 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.73 | Np Likeness Score: -1.88 |
1. Gentles RG, Hu S, Huang Y, Grant-Young K, Poss MA, Andres C, Fiedler T, Knox R, Lodge N, Weaver CD, Harden DG.. (2008) Preliminary SAR studies on non-apamin-displacing 4-(aminomethylaryl)pyrrazolopyrimidine K(Ca) channel blockers., 18 (20): [PMID:18824351] [10.1016/j.bmcl.2008.08.026] |
Source(1):